Chromosomal aberrations induced by chemotherapy and radiotherapy in lymphocytes from patients with breast carcinoma.

[1]  C. Rubino,et al.  Increased risk of second cancers following breast cancer: Role of the initial treatment , 2000, Breast Cancer Research and Treatment.

[2]  A. Kiltie,et al.  Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  M. Durante,et al.  Complex-type chromosomal exchanges in blood lymphocytes during radiation therapy correlate with acute toxicity. , 2000, Cancer letters.

[4]  M. Molls,et al.  Follow-up analysis of translocation and dicentric frequencies, measured by FISH-chromosome painting in breast cancer patients after partial-body radiotherapy with little bone marrow exposure. , 1999, Mutation research.

[5]  G. Stephan,et al.  The influence of age, sex and smoking habits on the background level of fish-detected translocations. , 1999, Mutation research.

[6]  B. Caillou,et al.  Radiosensitivity of human normal and tumoral thyroid cells using fluorescence in situ hybridization and clonogenic survival assay. , 1999, International journal of radiation oncology, biology, physics.

[7]  D. W. Abbott,et al.  Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells. , 1998, Journal of the National Cancer Institute.

[8]  D. Nelson,et al.  Persistence of radiation-induced translocations in human peripheral blood determined by chromosome painting. , 1998, Radiation research.

[9]  M. King,et al.  Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. , 1998, JAMA.

[10]  V. Durand,et al.  Is FISH painting an appropriate biological marker for dose estimates of suspected accidental radiation overexposure? A review of cases investigated in France from 1995 to 1996. , 1997, Environmental health perspectives.

[11]  J. Dunst,et al.  The impact of complex chromosomal rearrangements on the detection of radiosensitivity in cancer patients. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  J Nyman,et al.  Prognostic factors for acute and late skin reactions in radiotherapy patients. , 1996, International Journal of Radiation Oncology, Biology, Physics.

[13]  M. Schlumberger,et al.  Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  A. Udayakumar,et al.  Persistence of chromosomal aberrations in blood lymphocytes 11 years after cessation of CMF therapy in a breast cancer patient. , 1996, Cancer letters.

[15]  J. Lucas,et al.  Stability of the translocation frequency following whole-body irradiation measured in rhesus monkeys. , 1996, International journal of radiation biology.

[16]  R. Marcos,et al.  Cytogenetic analysis in peripheral lymphocytes of cancer patients treated with cytostatic drugs: results from an EC Collaborative Study. , 1996, Anti-cancer drugs.

[17]  R. Arnold,et al.  The role of stable chromosome aberrations as biological indicators of radiation effect: studies in patients after total body irradiation and bone marrow transplantation. , 1995, Stem cells.

[18]  J. Yarnold,et al.  The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules , 1994 .

[19]  H. Bartelink,et al.  Use of fluorescence in situ hybridization to measure chromosome aberrations as a predictor of radiosensitivity in human tumour cells. , 1994, International journal of radiation biology.

[20]  H. Magdelenat,et al.  Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. II. Alteration of DNA repair and chromosome radiosensitivity. , 1990, Mutation research.

[21]  A. Rademaker,et al.  A comparison of chromosomal aberrations induced by in vivo radiotherapy in human sperm and lymphocytes. , 1989, Mutation research.

[22]  N. Willich,et al.  Time-effect relationship of chromosome aberrations in peripheral lymphocytes after radiation therapy for seminoma. , 1989, Mutation research.

[23]  W. Hittelman,et al.  The relationship of DNA and chromosome damage to survival of synchronized X-irradiated L5178Y cells. I. Initial damage. , 1988, Radiation research.

[24]  W. Hittelman,et al.  The relationship of DNA and chromosome damage to survival of synchronized X-irradiated L5178Y cells. II. Repair. , 1988, Radiation research.

[25]  J. Weber,et al.  Chromosome aberrations induced in human lymphocytes by an X-radiation accident: results of a 4-year postirradiation analysis. , 1988, International journal of radiation biology.

[26]  A. Neugut,et al.  Clinical Aspects of Postirradiation Sarcomas1 , 1988 .

[27]  A. Kagan,et al.  The importance of genetics for the optimization of radiation therapy. A hypothesis. , 1988, American journal of clinical oncology.

[28]  E. Gebhart,et al.  Chromosome studies on lymphocytes of patients under cytostatic therapy , 1980, Human Genetics.

[29]  N. Bianchi,et al.  Kinetics of human lymphocyte division and chromosomal radiosensitivity. , 1979, Mutation research.

[30]  B. Lambert,et al.  Persistence of chromosome rearrangements in peripheral lymphocytes from patients treated with melphalan for ovarian carcinoma , 2004, Human Genetics.

[31]  F. Eschwège,et al.  Biological dosimetry after total body irradiation (TBI) for hematologic malignancy patients. , 2000, International journal of radiation oncology, biology, physics.

[32]  S. Roberts,et al.  Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. , 1999, International journal of radiation biology.

[33]  G. Casey.  The BRCA1 and BRCA2 breast cancer genes. , 1997, Current opinion in oncology.

[34]  J. Dunst,et al.  Use of a three-color chromosome in situ suppression technique for the detection of past radiation exposure. , 1996, Radiation research.

[35]  A. Wambersie,et al.  Dose-effect relationship for in vivo and in vitro induction of dicentric aberrations in blood lymphocytes of children. , 1995, Radiation research.

[36]  R. Cowan,et al.  Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. , 1995, International journal of radiation biology.

[37]  M. Lemaire,et al.  Chromosome aberrations in circulating lymphocytes after brachytherapy for uterus carcinoma. , 1995, Acta oncologica.

[38]  J. Lebesque,et al.  Lack of correlation of human fibroblast radiosensitivity in vitro with early skin reactions in patients undergoing radiotherapy. , 1993, International journal of radiation biology.

[39]  J. Tucker,et al.  Validation of chromosome painting as a biodosimeter in human peripheral lymphocytes following acute exposure to ionizing radiation in vitro. , 1993, International journal of radiation biology.

[40]  M. Kovacs,et al.  The prediction of human tumor radiosensitivity in situ: an approach using chromosome aberrations detected by fluorescence in situ hybridization. , 1992, International journal of radiation oncology, biology, physics.

[41]  J. Brown,et al.  The frequency of translocations after treatment for Hodgkin's disease. , 1992, International journal of radiation oncology, biology, physics.

[42]  D. Provisor,et al.  Acute mxyeloblastic leukemia two years after diagnosis of non‐Hodgkin lymphoma , 1979 .